The New York based Bristol Myers Squibb Co (NYSE:BMY) has made a pact under which Reckitt Benckiser Group Plc (LON: RB) will pay it an upfront almost of $438 million for the exclusive rights to vend certain over-the-counter medicines across Latin America for 3 years.
Chief Financial Officer of BMY Charles Bancroft reported that Bristol-Myers Squibb has worked to concentrate on its units around the world on innovative medicines in areas of high unmet medical need as part of their BioPharma strategy.
At the current trading session, Bristol Myers Squibb Co (NYSE:BMY) shares down -0.41% to $36.78 while The Stock traded within the range of $36.70 – $36.96. In the past year, the stock has traded within a range of $30.64 – $37.09. The current session’s volume of 644,802.00 shares is down from the average daily trading volume of 10.21 million shares.
The McGraw-Hill Companies, Inc (NYSE:MHP) returned to loss in fiscal Q4 as the corporation booked a key loss from its education unit, although it continued to observe strong revenue expansion from its Standard & Poor’s ratings segment.
McGraw-Hill reported that it projects earnings for the year of $3.10 to $3.20 per share, well lower than the $3.80 per share forecasted by Thomson Reuters analysts survey.
The McGraw-Hill Companies, Inc (NYSE:MHP) shares are down -0.52% to $44.06 while the stock is traded within the range of $43.63 – $44.60 in the current trading session. In the last 12 months the shares have traded between $42.02 and $58.62. The current session’s volume of 1.24 million shares is lower than their average daily trading volume of 4.76 million shares.
Barclays PLC (ADR) (NYSE:BCS) reported on Tuesday that it will lower thousands of employments to cut its expenses in the coming 3 years as part of a strategy restructuring outlined by CEO Antony Jenkins.
Europe’s biggest bank announced a net loss of GBP 1.04 billion for 2012, after a net profit of GBP 3 billion in 2011, mostly due to a non-cash charge from the rising value of its own debt.
Another rival company, Barclays PLC (ADR) (NYSE:BCS) is trading up +7.59% to $20.26. Intraday trading recorded the stock price in a range of $20.06 to $20.28. In the previous 52 weeks the stock’s price ranged between $9.23 and $20.28. Their average daily trading volume is 1.65 million shares.
DO NOT TRADE ANY STOCK WITHOUT LEVEL 2 STOCK QUOTES! QuoteDaddy.com delivers it's user with the most in-depth Level 2 Quotation System available on the Planet! NO Downloads, NO Widgets, NO Plugins required! Stay on TOP of your trades with QuoteDaddy.com! CLICK HERE TO START YOUR FREE 30-DAY TRIAL